Zdrowie i gospodarka · 27.10.1994
Adverse Experience Reporting Requirements for Licensed Biological Products
The Food and Drug Administration (FDA) is amending the regulations to require manufacturers of licensed biological products (hereinafter referred to as licensed manufacturers) to report to FDA within 15 working days all adverse experiences associated with the use of a biological product that are both serious and unexpected; any significant increase in the frequency of a serious, but expected adverse experience; periodically, all other adverse experiences; and product distribution and disposition data. FDA is taking this action to provide a mechanism under which licensed manufacturers would inform the agency, on a timely basis, of any unanticipated safety problems with marketed biological products.